Ad
related to: neurodegenerative diseases
Search results
What Does a Lonely Brain Look Like?
New York Times· 6 days agoFeeling chronically disconnected from others can affect the brain’s structure and function, and it raises the risk for neurodegenerative diseases. It...
Morning Brew: Tesla Announces Expansion Plans, Tech Stocks React
Guru Focus· 6 days agoStock market futures indicate a lower opening today, with S&P 500 futures down by ten points, Nasdaq...
Amylyx Pharmaceuticals Reports Q1 2024 Financial Results
GuruFocus.com via Yahoo Finance· 5 days agoThe Cambridge, Massachusetts-based biopharmaceutical company, known for its focus on ...
A promising new study could lead to a reduction in symptoms of amyotrophic lateral sclerosis (ALS)
The Conversation· 2 days agoEvery year roughly 1,000 Canadians are diagnosed with amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s disease). As neuroscience researchers, we are dedicated to finding ways to ...
VidaCaixa creates a panel of experts for senior citizens
Hardwood Paroxysm· 7 days agoThe company, which increased its first-quarter earnings by 8%, to $298 million, commissioned this...
The five worst ultra-processed foods you need to avoid
Yahoo Life UK· 5 days ago(Getty Images) Getty In the years that followed, scientists identified 48,193 deaths from cancer,...
Butter vs. margarine: Is one 'better' for you than the other?
Fox News via Yahoo News· 1 day agoIs butter or margarine better for you? Here is what you should know about both spreads' health and...
AlzeCure Reports Anti-Inflammatory Effects with NeuroRestore ACD856 with Relevance to Alzheimer's...
Digital Journal· 2 days agoSTOCKHOLM, SWEDEN / ACCESSWIRE / May 13, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases ...
Vowel intelligibility testing may help monitor progression for people with ALS
Medical Xpress· 7 days agoALS, commonly referred to as Lou Gehrig's disease, is a progressive neurodegenerative disease that affects the nerve cells that make muscles work. In a ...
Eisai initiates rolling Biologics License Application to US FDA for Leqembi® (lecanemab-irmb) for...
WROC Rochester· 12 hours agoBioArctic AB's (publ) (NASDAQ STOCKHOLM: BIOA B) partner Eisai announced today that they have...